C0025611||Methamphetamine
C0115471||3,4-methylenedioxymethamphetamine
C0115471||3,4-methylenedioxymethamphetamine
C2974592||3,4-methylenedioxypyrovalerone
C2974592||3,4-methylenedioxypyrovalerone
C0596402||cytotoxic effects
C0007452||bovine
C0006104||brain
C2350570||microvessel
C0225336||endothelial cells
C0011684||Designer drugs
C0304403||synthetic psychostimulants
C0033213||problem
C0013146||drug abuse
C1510472||addiction
C0025611||methamphetamine
C0025611||methamphetamine
C0011684||drugs
C0115471||3,4-methylenedioxy-methamphetamine
C0115471||3,4-methylenedioxymethamphetamine
C0680536||commercial
C0054876||synthetic cathinones
C2974592||3,4-methylenedioxypyrovalerone
C2974592||3,4-methylenedioxypyrovalerone
C0771243||bath salts
C0304403||psychostimulants
C0235032||neurotoxic effects
C0006104||brain
C0025611||methamphetamine
C0115471||3,4-methylenedioxymethamphetamine
C0879626||adversely affect
C0005854||blood-brain barrier
C0005854||blood-brain barrier
C0684224||reports
C2974592||3,4-methylenedioxypyrovalerone
C0005854||blood-brain barrier
C2603343||study
C0025611||methamphetamine
C0115471||3,4-methylenedioxymethamphetamine
C2974592||3,4-methylenedioxypyrovalerone
C0007452||bovine
C0006104||brain
C2350570||microvessel
C0225336||endothelial cells
C0225336||bovine brain microvessel endothelial cells
C1515654||in vitro model
C0005854||blood-brain barrier
C0225336||bBMVEC
C0934502||monolayers
C0025611||methamphetamine
C0115471||3,4-methylenedioxymethamphetamine
C2974592||3,4-methylenedioxypyrovalerone
C0025611||methamphetamine
C0115471||3,4-methylenedioxymethamphetamine
C0022917||lactate dehydrogenase
C2974592||3,4-methylenedioxypyrovalerone
C0596402||cytotoxicity
C0115471||3,4-methylenedioxymethamphetamine
C0025611||methamphetamine
C0596290||cellular proliferation
C2974592||3,4-methylenedioxypyrovalerone
C2974592||3,4-methylenedioxypyrovalerone
C0162772||reactive oxygen species
C0011684||drugs
C0028128||nitric oxide
C0936012||Morphological analysis
C1706082||compound
C0025611||methamphetamine
C0042219||vacuole
C0934502||monolayer
C0115471||3,4-methylenedioxymethamphetamine
C0225336||endothelial
C0934502||monolayer
C0010840||vacuolization
C2974592||3,4-methylenedioxypyrovalerone
C0934502||monolayer
C0042219||vacuole
C0007634||cells
C0304403||synthetic psychostimulants
C0005854||blood-brain barrier
C0013221||toxicity
C2974592||3,4-methylenedioxypyrovalerone